BRIEF published on 11/19/2024 at 08:05, 4 days 1 hour ago Share capital and voting rights of Robertet as of November 18, 2024 Euronext Paris Share Capital Voting Rights Actions Robertet
BRIEF published on 11/15/2024 at 17:05, 7 days 16 hours ago ROBERTET Rectifies an Error in His Previous Press Release Press Release Robertet Long Term Growth Error Corrected Exchange Parity
PRESS RELEASE published on 11/15/2024 at 17:00, 7 days 16 hours ago Addendum to the press release of November 15, 2024 A correction has been made to the press release of November 15, 2024 regarding the exchange ratio of Investment and Voting Rights Certificates, now updated on the Robertet website Press Release Shareholder Base Correction Exchange Ratio Robertet
BRIEF published on 11/15/2024 at 07:40, 8 days 1 hour ago Evolution of Robertet's shareholding to support its growth PEUGEOT INVEST Growth Shareholding Robertet FSP
PRESS RELEASE published on 11/15/2024 at 07:35, 8 days 1 hour ago ROBERTET SUCCESSFULLY RESHAPES ITS SHAREHOLDER BASE TO SUPPORT LONG-TERM GROWTH AMBITIONS Robertet reshapes shareholder base for long-term growth with new investors FSP and Peugeot Invest, reinforcing ownership and governance. Market transaction expands free float by 6% PEUGEOT INVEST Free Float Shareholder Base Robertet Fonds Stratégique De Participations
BRIEF published on 11/14/2024 at 18:40, 8 days 14 hours ago Evolution of Robertet's shareholding PEUGEOT INVEST Shareholding Investments Robertet Strategic Fund
PRESS RELEASE published on 11/14/2024 at 18:35, 8 days 14 hours ago EVOLUTION OF ROBERTET'S SHAREHOLDING Robertet's shareholder base is reshaped with a stronger position of Maubert SA, the entry of Fonds Stratégique de Participations and Peugeot Invest, following an accelerated book-building process initiated by dsm-firmenich Shareholder Base Robertet Fonds Stratégique De Participations Accelerated Book-building Maubert SA
BRIEF published on 11/04/2024 at 18:00, 18 days 15 hours ago Robertet strengthens its presence in North America with the acquisition of Phasex Acquisition North America Robertet Supercritical CO2 Phasex
PRESS RELEASE published on 11/04/2024 at 17:55, 18 days 15 hours ago ROBERTET ANNOUNCES THE ACQUISITION OF PHASEX, A PIONEER IN SUPERCRITICAL CO2 EXTRACTION IN THE UNITED STATES Robertet acquires Phasex, a pioneer in supercritical CO2 extraction for natural products, expanding manufacturing capacity and expertise in North America North America Natural Products Robertet Phasex Supercritical CO2 Extraction
BRIEF published on 09/24/2024 at 09:20, 1 month 28 days ago AVAILABILITY OF THE 2024 HALF-YEARLY FINANCIAL REPORT Financial Report 2024 Half-yearly Robertet Available
Published on 11/22/2024 at 23:55, 9 hours 21 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 46 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 11 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 46 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 1 minute ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 22 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 20 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 15 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
